NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









hema.to

hema.to

Private
MunichHealthcare & Life Scienceshttps://www.hema.to/

Last Round

Seed

Feb 27, 2025

Total Funding Raised

$7.71M

Company Overview

hema.to is a medtech company that provides a cloud-based software-as-a-service (SaaS) platform using artificial intelligence to automate the analysis of blood data for diagnostic support.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, Vertical SaaS, Precision Medicine

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

flow cytometryclinical flow cytometrydiagnostic supportmedical AIpathology AIhematology softwareflow cytometry analysisCE-IVDworkflow automationB2B SaaSprecision medicinedigital pathologyautomated gatinglab informaticsmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

hema.to Comparables

Compare hema.to with similar companies based on industry and business-model similarity.

hema.to comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AHEAD Medicine
90%
FlowView Diagnostics BV
85%
METAFORA Biosystems
82%

hema.to Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 27, 2025
SeedJun 26, 2023

Key People

Founding team and executive leadership

Felix Kunzweiler

Co-Founder & CTO

Founding Team

Karsten Miermans

Chief Executive Officer

Executive Team

Daniel Moritz

Interim Chief Financial Officer

Executive Team

hema.to Investors

Notable investors and investment history

hema.to Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

hema.to Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about hema.to's valuation, stock price, and market status.

Firmographic Details

HeadquartersMunich
Employee Range18
Year Founded2021
Last FundingFeb 27, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.